panobinostat [Ligand Id: 7489] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL483254 (Farydak, LBH-589, LBH589, Panobinostat, Panobinostat hydrate) |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| bromodomain containing 4/Bromodomain-containing protein 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1163125] [GtoPdb: 1945] [UniProtKB: O60885] | ||||||||
| ChEMBL | Inhibition of BRD4 (unknown origin) | B | 8.3 | pIC50 | 5 | nM | IC50 | Bioorg Med Chem Lett (2017) 27: 4051-4055 [PMID:28765013] |
| Histone deacetylase in Plasmodium falciparum (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5541] [UniProtKB: Q9XYC7] | ||||||||
| ChEMBL | Inhibition of HDAC1 in Plasmodium falciparum 3D7 nuclear extract using Ac-RGK(Ac)-AMC fluorogenic peptide as substrate preincubated for 1 hr followed by substrate addition measured after 10 min by fluorescence assay | B | 8.48 | pIC50 | 3.3 | nM | IC50 | J Med Chem (2017) 60: 4780-4804 [PMID:28241112] |
| ChEMBL | Inhibition of Plasmodium falciparum HDAC1 expressed in Drosophila melanogaster S2 cells | B | 8.74 | pIC50 | 1.8 | nM | IC50 | J Med Chem (2009) 52: 2185-2187 [PMID:19317450] |
| histone deacetylase 1/Histone deacetylase 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL325] [GtoPdb: 2658] [UniProtKB: Q13547] | ||||||||
| ChEMBL | Inhibition of human recombinant HDAC1 using fluorogenic HDAC substrate after 15 mins by fluorimetrc method | B | 8.52 | pKi | 3 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Competitive inhibition of HDAC1 using KI-104 as substrate by fluorescence assay | B | 8.6 | pKi | 2.5 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of human HDAC1 | B | 9 | pKi | 1 | nM | Ki | Nat Chem Biol (2010) 6: 238-243 [PMID:20139990] |
| ChEMBL | Inhibition of human HDAC1 | B | 9 | pKi | 1 | nM | Ki | Bioorg Med Chem (2015) 23: 5151-5155 [PMID:25637120] |
| ChEMBL | Inhibition of human recombinant HDAC1 using Fluor de Lys as substrate after 2 hrs by fluorescence method | B | 9.27 | pKi | 0.54 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Inhibition of HDAC1 (unknown origin) after 60 mins by fluorescence assay | B | 6.52 | pIC50 | <300 | nM | IC50 | J Med Chem (2013) 56: 4816-4820 [PMID:23672185] |
| ChEMBL | Inhibition of human recombinant HDAC1 pre-incubated for 30 mins before substrate addition and measured after 30 mins by fluorescence based assay | B | 7.59 | pIC50 | 26 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 2581-2586 [PMID:31400937] |
| ChEMBL | Inhibition of human KDAC1 using substrate A after 60 mins by fluorescence assay | B | 7.7 | pIC50 | 20 | nM | IC50 | Eur J Med Chem (2017) 127: 531-553 [PMID:28109947] |
| ChEMBL | Inhibition of HDAC1 (unknown origin) | B | 7.82 | pIC50 | 15 | nM | IC50 | J Med Chem (2022) 65: 3080-3097 [PMID:35148101] |
| ChEMBL | Inhibition of HADC1 (unknown origin) | B | 7.82 | pIC50 | <15 | nM | IC50 | J Med Chem (2020) 63: 23-39 [PMID:31415174] |
| ChEMBL | Inhibition of recombinant His6/GST-tagged human HDAC1 expressed in baculovirus infected High5 insect cells using Ac-Lys-Tyr-Lys(epsilon-acetyl)-AMC as substrate after 24 hrs by fluorescence based assay | B | 8.15 | pIC50 | 7.03 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of full length recombinant HDAC1 using Fluor de Lys as substrate by fluorescence assay | B | 8.17 | pIC50 | 6.8 | nM | IC50 | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of HDAC1 (unknown origin) | B | 8.52 | pIC50 | 3 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| ChEMBL | Inhibition of recombinant HDAC1 (unknown origin) | B | 8.6 | pIC50 | 2.5 | nM | IC50 | J Med Chem (2021) 64: 3392-3426 [PMID:33661013] |
| ChEMBL | Inhibition of recombinant HDAC1 (unknown origin) | B | 8.6 | pIC50 | 2.5 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant HDAC1 (unknown origin) using Boc-Lys(acetyl)-AMC as substrate preincubated for 1 hr followed by substrate addition and measured after 2 hrs by fluorescence based micro plate reader analysis | B | 8.6 | pIC50 | 2.5 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of HDAC1 (unknown origin) expressed in HEK293 cells using [3H]acetylated human histone H4 peptide as substrate by scintillation counting | B | 8.6 | pIC50 | 2.5 | nM | IC50 | Drug Metab Dispos (2012) 40: 1041-1050 [PMID:22344701] |
| ChEMBL | Inhibition of recombinant human HDAC1 using Boc-Lys(acetyl)-AMC as substrate preincubated for 90 mins followed by substrate addition and measured after 2 hrs by fluorescence based microplate reader analysis | B | 8.67 | pIC50 | 2.14 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant human HDAC1 using Boc-Lys(acetyl)-AMC as substrate preincubated for 60 mins followed by substrate addition and measured after 2 hrs by fluorescence based microplate reader analysis | B | 8.67 | pIC50 | 2.12 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant human HDAC1 using Boc-Lys(acetyl)-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 2 hrs by fluorescence based microplate reader analysis | B | 8.74 | pIC50 | 1.81 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant human HDAC1 using Boc-Lys(acetyl)-AMC as substrate preincubated for 30 mins followed by substrate addition and measured after 2 hrs by fluorescence based microplate reader analysis | B | 8.75 | pIC50 | 1.78 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of HDAC1 (unknown origin) | B | 8.85 | pIC50 | 1.4 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| ChEMBL | Inhibition of full length C-terminal His/FLAG-tagged human recombinant HDAC1 expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 8.9 | pIC50 | 1.26 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| ChEMBL | Inhibition of C-terminal His-tagged and C-terminal FLAG-tagged full length human recombinant HDAC1 expressed in baculovirus coexpressed in fall armyworm Sf9 cells using carboxyfluorescein (FAM)-labeled acetylated/ trifluoroacetylated peptide as substrate after 60 mins by fluorescence assay | B | 9 | pIC50 | 1 | nM | IC50 | Bioorg Med Chem (2016) 24: 4008-4015 [PMID:27377864] |
| ChEMBL | Inhibition of human recombinant HDAC1 using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 9 | pIC50 | 1 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition of recombinant human full-length C-terminal FLAG-tagged HDAC1 expressed in baculovirus expression system using Ac-peptide-AMC as substrate preincubated for 15 mins followed by substrate addition by fluorescence assay | B | 9.22 | pIC50 | 0.6 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 2136-2140 [PMID:31272794] |
| ChEMBL | Inhibition of HDAC1 (unknown origin) using Ac-peptide-AMC as substrate incubated for 1 hr by fluorescence method | B | 9.3 | pIC50 | 0.5 | nM | IC50 | J Med Chem (2021) 64: 15379-15401 [PMID:34648295] |
| GtoPdb | - | - | 8.52 | pEC50 | 3 | nM | EC50 | Biochem J (2008) 409: 581-9 [PMID:17868033] |
| histone deacetylase 10/Histone deacetylase 10 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5103] [GtoPdb: 2614] [UniProtKB: Q969S8] | ||||||||
| ChEMBL | Competitive inhibition of HDAC10 using KI-104 as substrate by fluorescence assay | B | 7.51 | pKi | 31 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of human recombinant HDAC10 using fluorogenic HDAC substrate after 45 mins by fluorimetrc method | B | 8.29 | pKi | 5.1 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Inhibition of recombinant human His6/GST-tagged HDAC10 expressed in baculovirus infected High5 insect cells using Ac-Lys-Tyr-Lys(epsilon-acetyl)-AMC as susbtrate after 24 hrs by fluorescence based assay | B | 7.99 | pIC50 | 10.24 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of human recombinant HDAC10 expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 8.35 | pIC50 | 4.45 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| ChEMBL | Inhibition of recombinant HDAC10 (unknown origin) using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 8.4 | pIC50 | 4 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition of human recombinant HDAC10 using Boc-Lys(triflouroacetyI)-AMC substrate incubated for 2 hrs by fluorescence based assay | B | 8.64 | pIC50 | 2.3 | nM | IC50 | J Med Chem (2022) 65: 285-302 [PMID:34942071] |
| ChEMBL | Inhibition of HDAC10 (unknown origin) | B | 8.68 | pIC50 | 2.1 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| ChEMBL | Inhibition of HDAC10 (unknown origin) | B | 8.7 | pIC50 | 2 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| histone deacetylase 11/Histone deacetylase 11 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3310] [GtoPdb: 2615] [UniProtKB: Q96DB2] | ||||||||
| ChEMBL | Inhibition of human recombinant HDAC11 using fluorogenic HDAC substrate class 2a after 30 mins by fluorimetrc method | B | 5.92 | pKi | 1200 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Competitive inhibition of HDAC11 using KI-104 as substrate by fluorescence assay | B | 8.46 | pKi | 3.5 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of recombinant HDAC11 (unknown origin) using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 5.39 | pIC50 | 4112 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition of full length human recombinant HDAC11 expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 5.39 | pIC50 | 4112 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| ChEMBL | Inhibition of recombinant human His6/GST-tagged HDAC11 expressed in baculovirus infected High5 insect cells using Ac-Lys-Tyr-Lys(epsilon-acetyl)-AMC as susbtrate after 24 hrs by fluorescence based assay | B | 6.92 | pIC50 | 121 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of HDAC11 (unknown origin) | B | 8.52 | pIC50 | 3 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| ChEMBL | Inhibition of human recombinant HDAC11 using Boc-Lys(triflouroacetyI)-AMC substrate incubated for 2 hrs by fluorescence based assay | B | 8.57 | pIC50 | 2.7 | nM | IC50 | J Med Chem (2022) 65: 285-302 [PMID:34942071] |
| ChEMBL | Inhibition of HDAC11 (unknown origin) | B | 8.8 | pIC50 | 1.6 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| histone deacetylase 2/Histone deacetylase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1937] [GtoPdb: 2616] [UniProtKB: Q92769] | ||||||||
| ChEMBL | Inhibition of human recombinant HDAC2 using fluorogenic HDAC substrate after 15 mins by fluorimetrc method | B | 7.66 | pKi | 22 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Inhibition of C-terminal GST-tagged recombinant human HDAC2 (1 to 488 residues) expressed in Baculovirus infected insect cells using Boc-Lys(Ac)-AMC as substrate preincubated for 5 mins followed by substrate addition and further incubation for 90 mins measured after 15 mins by microplate reader based fluorescence assay | B | 7.89 | pKi | 13 | nM | Ki | Bioorg Med Chem (2019) 27: 115036-115036 [PMID:31431326] |
| ChEMBL | Competitive inhibition of HDAC2 using KI-104 as substrate by fluorescence assay | B | 8.72 | pKi | 1.9 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of human HDAC2 | B | 9.15 | pKi | 0.7 | nM | Ki | Bioorg Med Chem (2015) 23: 5151-5155 [PMID:25637120] |
| ChEMBL | Inhibition of human HDAC2 | B | 9.19 | pKi | 0.65 | nM | Ki | Nat Chem Biol (2010) 6: 238-243 [PMID:20139990] |
| ChEMBL | Inhibition of HDAC2 (unknown origin) after 60 mins by fluorescence assay | B | 6.52 | pIC50 | <300 | nM | IC50 | J Med Chem (2013) 56: 4816-4820 [PMID:23672185] |
| ChEMBL | Inhibition of human recombinant HDAC2 pre-incubated for 30 mins before substrate addition and measured after 30 mins by fluorescence based assay | B | 6.87 | pIC50 | 136 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 2581-2586 [PMID:31400937] |
| ChEMBL | Inhibition of recombinant human His6/GST-tagged HDAC2 expressed in baculovirus infected High5 insect cells using Ac-Lys-Tyr-Lys(epsilon-acetyl)-AMC as susbtrate after 24 hrs by fluorescence based assay | B | 7.64 | pIC50 | 22.83 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of recombinant HDAC2 (unknown origin) | B | 7.88 | pIC50 | 13.2 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant human HDAC2 expressed in baculovirus expression system using Boc-Lys(acetyl)-AMC as substrate preincubated for 1 hr followed by substrate addition and measured after 2 hrs by fluorescence based micro plate reader analysis | B | 7.88 | pIC50 | 13.2 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant HDAC2 (unknown origin) | B | 7.88 | pIC50 | 13.2 | nM | IC50 | J Med Chem (2021) 64: 3392-3426 [PMID:33661013] |
| ChEMBL | Inhibition of HDAC2 (unknown origin) | B | 7.89 | pIC50 | 13 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| ChEMBL | Inhibition of flag-tagged HDAC2 (unknown origin) expressed in SF21 cells using [3H]acetylated human histone H4 peptide as substrate by scintillation counting | B | 7.89 | pIC50 | 13 | nM | IC50 | Drug Metab Dispos (2012) 40: 1041-1050 [PMID:22344701] |
| ChEMBL | Inhibition of HDAC2 (unknown origin) | B | 8.17 | pIC50 | 6.8 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| ChEMBL | Inhibition of full length human recombinant HDAC2 expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 8.48 | pIC50 | 3.28 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| ChEMBL | Inhibition of recombinant HDAC2 (unknown origin) using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 8.52 | pIC50 | 3 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition full length human recombinant HDAC2 expressed in baculovirus coexpressed in fall armyworm Sf9 cells using carboxyfluorescein (FAM)-labeled acetylated/ trifluoroacetylated peptide as substrate after 60 mins by fluorescence assay | B | 8.7 | pIC50 | 2 | nM | IC50 | Bioorg Med Chem (2016) 24: 4008-4015 [PMID:27377864] |
| GtoPdb | - | - | 8.52 | pEC50 | 3 | nM | EC50 | Biochem J (2008) 409: 581-9 [PMID:17868033] |
| histone deacetylase 3/Histone deacetylase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1829] [GtoPdb: 2617] [UniProtKB: O15379] | ||||||||
| ChEMBL | Inhibition of human recombinant HDAC3 using fluorogenic HDAC substrate after 10 mins by spectrophotometric method | B | 8.62 | pKi | 2.4 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Competitive inhibition of HDAC3 using KI-104 as substrate by fluorescence assay | B | 8.64 | pKi | 2.3 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of human HDAC3 | B | 8.96 | pKi | 1.1 | nM | Ki | Nat Chem Biol (2010) 6: 238-243 [PMID:20139990] |
| ChEMBL | Inhibition of human HDAC3 | B | 8.96 | pKi | 1.1 | nM | Ki | Bioorg Med Chem (2015) 23: 5151-5155 [PMID:25637120] |
| ChEMBL | Inhibition of HDAC3 (unknown origin) after 60 mins by fluorescence assay | B | 6.52 | pIC50 | <300 | nM | IC50 | J Med Chem (2013) 56: 4816-4820 [PMID:23672185] |
| ChEMBL | Inhibition of human KDAC3 using FITC-labeled p53 acetylated peptide as substrate after 60 mins by fluorescence assay | B | 7.22 | pIC50 | 60 | nM | IC50 | Eur J Med Chem (2017) 127: 531-553 [PMID:28109947] |
| ChEMBL | Inhibition of HDAC3 (unknown origin) | B | 7.82 | pIC50 | 15 | nM | IC50 | J Med Chem (2022) 65: 3080-3097 [PMID:35148101] |
| ChEMBL | Inhibition of HADC3 (unknown origin) | B | 7.82 | pIC50 | <15 | nM | IC50 | J Med Chem (2020) 63: 23-39 [PMID:31415174] |
| ChEMBL | Inhibition of recombinant His6/GST-tagged human HDAC3 expressed in baculovirus infected High5 insect cells using Ac-Lys-Tyr-Lys(epsilon-acetyl)-AMC as substrate after 24 hrs by fluorescence based assay | B | 8.23 | pIC50 | 5.83 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of HDAC3 (unknown origin) expressed in HEK293 cells using [3H]acetylated human histone H4 peptide as substrate by scintillation counting | B | 8.68 | pIC50 | 2.1 | nM | IC50 | Drug Metab Dispos (2012) 40: 1041-1050 [PMID:22344701] |
| ChEMBL | Inhibition of recombinant HDAC3 (unknown origin) | B | 8.68 | pIC50 | 2.1 | nM | IC50 | J Med Chem (2021) 64: 3392-3426 [PMID:33661013] |
| ChEMBL | Inhibition of recombinant HDAC3 (unknown origin) | B | 8.68 | pIC50 | 2.1 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of HDAC3 (unknown origin) | B | 8.7 | pIC50 | 2 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| ChEMBL | Inhibition of recombinant HDAC3 (unknown origin) using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 8.7 | pIC50 | 2 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition full length human recombinant HDAC3 expressed in baculovirus using carboxyfluorescein (FAM)-labeled acetylated/ trifluoroacetylated peptide as substrate after 60 mins by fluorescence assay | B | 8.7 | pIC50 | 2 | nM | IC50 | Bioorg Med Chem (2016) 24: 4008-4015 [PMID:27377864] |
| ChEMBL | Inhibition of HDAC3 (unknown origin) | B | 8.82 | pIC50 | 1.5 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| GtoPdb | - | - | 8.4 | pEC50 | 4 | nM | EC50 | Biochem J (2008) 409: 581-9 [PMID:17868033] |
| histone deacetylase 3/Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2) in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111363] [GtoPdb: 2617] [UniProtKB: O15379, Q9Y618] | ||||||||
| ChEMBL | Inhibition of full length C-terminal His-tagged human recombinant HDAC3/NCOR2 (395 to 489 residues) expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 8.64 | pIC50 | 2.27 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| ChEMBL | Inhibition of recombinant human C-terminal GST/His-tagged HDAC3 (1 to 428 residues) co-expressed with human N-terminal GST-tagged NCOR2 (395 to 489 residues) in baculovirus infected Sf9 cells using Boc-Lys(acetyl)-AMC as substrate preincubated for 1 hr followed by substrate addition and measured after 2 hrs by fluorescence based micro plate reader analysis | B | 8.68 | pIC50 | 2.1 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant human C-terminal GST/His-tagged HDAC3 (1 to 428 residues) co-expressed with human N-terminal GST-tagged NCOR2 (395 to 489 residues) in baculovirus infected Sf9 cells using Boc-Lys(acetyl)-AMC as substrate preincubated for 90 mins followed by substrate addition and measured after 2 hrs by fluorescence based microplate reader analysis | B | 8.68 | pIC50 | 2.1 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant human C-terminal GST/His-tagged HDAC3 (1 to 428 residues) co-expressed with human N-terminal GST-tagged NCOR2 (395 to 489 residues) in baculovirus infected Sf9 cells using Boc-Lys(acetyl)-AMC as substrate preincubated for 60 mins followed by substrate addition and measured after 2 hrs by fluorescence based microplate reader analysis | B | 8.69 | pIC50 | 2.06 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant human C-terminal GST/His-tagged HDAC3 (1 to 428 residues) co-expressed with human N-terminal GST-tagged NCOR2 (395 to 489 residues) in baculovirus infected Sf9 cells using Boc-Lys(acetyl)-AMC as substrate preincubated for 10 mins followed by substrate addition and measured after 2 hrs by fluorescence based microplate reader analysis | B | 8.72 | pIC50 | 1.93 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant human C-terminal GST/His-tagged HDAC3 (1 to 428 residues) co-expressed with human N-terminal GST-tagged NCOR2 (395 to 489 residues) in baculovirus infected Sf9 cells using Boc-Lys(acetyl)-AMC as substrate preincubated for 30 mins followed by substrate addition and measured after 2 hrs by fluorescence based microplate reader analysis | B | 8.78 | pIC50 | 1.67 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| GtoPdb | - | - | 8.4 | pEC50 | 4 | nM | EC50 | Biochem J (2008) 409: 581-9 [PMID:17868033] |
| histone deacetylase 4/Histone deacetylase 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3524] [GtoPdb: 2659] [UniProtKB: P56524] | ||||||||
| ChEMBL | Inhibition of C-terminal His-tagged/N-terminal GST-tagged recombinant human HDAC4 (627 to 1084 residues) expressed in Baculovirus infected insect cells using Boc-Lys(TFa)-AMC as substrate preincubated for 5 mins followed by substrate addition and further incubation for 90 mins measured after 15 mins by microplate reader based fluorescence assay | B | 6.19 | pKi | 640 | nM | Ki | Bioorg Med Chem (2019) 27: 115036-115036 [PMID:31431326] |
| ChEMBL | Inhibition of human HDAC4 | B | 6.26 | pKi | 550 | nM | Ki | Nat Chem Biol (2010) 6: 238-243 [PMID:20139990] |
| ChEMBL | Inhibition of human HDAC4 | B | 6.26 | pKi | 550 | nM | Ki | Bioorg Med Chem (2015) 23: 5151-5155 [PMID:25637120] |
| ChEMBL | Inhibition of human recombinant HDAC4 using fluorogenic HDAC substrate class 2a after 30 mins by fluorimetrc method | B | 6.77 | pKi | 170 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Competitive inhibition of HDAC4 using KI-104 as substrate by fluorescence assay | B | 9.22 | pKi | 0.6 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of recombinant human His6/GST-tagged HDAC4 expressed in baculovirus infected High5 insect cells using Ac-Leu-Gly-Lys(Tfa)-AMC as substrate after 24 hrs by fluorescence based assay | B | 4.98 | pIC50 | 10390 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of human recombinant HDAC4 using Boc-Lys-(epsilon-Tfa)-AMC fluorogenic substrate incubated for 90 mins by fluorescence based assay | B | 6.32 | pIC50 | 480 | nM | IC50 | J Med Chem (2020) 63: 10339-10351 [PMID:32803970] |
| ChEMBL | Inhibition of N-terminal GST-tagged and C-terminal His-tagged human recombinant HDAC4 (627 to 1084 residues ) expressed in baculovirus coexpressed in fall armyworm Sf9 cells using carboxyfluorescein (FAM)-labeled acetylated/ trifluoroacetylated peptide as substrate after 60 mins by fluorescence assay | B | 6.43 | pIC50 | 373 | nM | IC50 | Bioorg Med Chem (2016) 24: 4008-4015 [PMID:27377864] |
| ChEMBL | Inhibition of recombinant HDAC4 (unknown origin) using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 6.47 | pIC50 | 338 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition of N-terminal GST/C-terminal His-tagged human recombinant HDAC4 (627 to 1084 residues) expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 6.47 | pIC50 | 337.8 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| ChEMBL | Inhibition of HDAC4 (unknown origin) after 60 mins by fluorescence assay | B | 6.52 | pIC50 | <300 | nM | IC50 | J Med Chem (2013) 56: 4816-4820 [PMID:23672185] |
| ChEMBL | Inhibition of HDAC4 (unknown origin) | B | 6.69 | pIC50 | 203 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| ChEMBL | Inhibition of recombinant HDAC4 (unknown origin) | B | 6.69 | pIC50 | 203 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of human recombinant HDAC4 using Boc-Lys(triflouroacetyI)-AMC substrate incubated for 2 hrs by fluorescence based assay | B | 6.69 | pIC50 | 203 | nM | IC50 | J Med Chem (2022) 65: 285-302 [PMID:34942071] |
| ChEMBL | Inhibition of HDAC4 (unknown origin) expressed in HEK293 cells using [3H]acetylated human histone H4 peptide as substrate by scintillation counting | B | 6.7 | pIC50 | 200 | nM | IC50 | Drug Metab Dispos (2012) 40: 1041-1050 [PMID:22344701] |
| ChEMBL | Inhibition of HDAC4 (unknown origin) | B | 7.57 | pIC50 | 26.7 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| GtoPdb | - | - | 7.92 | pEC50 | 12 | nM | EC50 | Biochem J (2008) 409: 581-9 [PMID:17868033] |
| histone deacetylase 5/Histone deacetylase 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2563] [GtoPdb: 2660] [UniProtKB: Q9UQL6] | ||||||||
| ChEMBL | Inhibition of human HDAC5 | B | 7.1 | pKi | 80 | nM | Ki | Nat Chem Biol (2010) 6: 238-243 [PMID:20139990] |
| ChEMBL | Inhibition of human HDAC5 | B | 7.1 | pKi | 80 | nM | Ki | Bioorg Med Chem (2015) 23: 5151-5155 [PMID:25637120] |
| ChEMBL | Inhibition of human recombinant HDAC5 using fluorogenic HDAC substrate class 2a after 30 mins by fluorimetrc method | B | 7.24 | pKi | 57 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Competitive inhibition of HDAC5 using KI-104 as substrate by fluorescence assay | B | 9.15 | pKi | 0.7 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of recombinant N-terminal GST-tagged full length human HDAC5 expressed in baculovirus infected Sf9 cells using Ac-Leu-Gly-Lys(Tfa)-AMC as substrate after 24 hrs by fluorescence based assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of HDAC5 (unknown origin) after 60 mins by fluorescence assay | B | 6.52 | pIC50 | <300 | nM | IC50 | J Med Chem (2013) 56: 4816-4820 [PMID:23672185] |
| ChEMBL | Inhibition of HDAC5 (unknown origin) using Ac-peptide as substrate preincubated for 15 mins followed by substrate addition by fluorescence assay | B | 6.54 | pIC50 | 290 | nM | IC50 | Eur J Med Chem (2021) 220: 113453-113453 [PMID:33957387] |
| ChEMBL | Inhibition of HDAC5 (unknown origin) | B | 6.71 | pIC50 | 195.6 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| ChEMBL | Inhibition of human recombinant HDAC5 expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 6.72 | pIC50 | 190.3 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| ChEMBL | Inhibition of recombinant HDAC5 (unknown origin) using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 6.72 | pIC50 | 190 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition of N-terminal GST-tagged full length human recombinant HDAC5 expressed in baculovirus coexpressed in fall armyworm Sf9 cells using carboxyfluorescein (FAM)-labeled acetylated/ trifluoroacetylated peptide as substrate after 60 mins by fluorescence assay | B | 7.04 | pIC50 | 92 | nM | IC50 | Bioorg Med Chem (2016) 24: 4008-4015 [PMID:27377864] |
| ChEMBL | Inhibition of HDAC5 (unknown origin) | B | 8.1 | pIC50 | 8 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| ChEMBL | Inhibition of human recombinant HDAC5 using Boc-Lys(triflouroacetyI)-AMC substrate incubated for 2 hrs by fluorescence based assay | B | 8.11 | pIC50 | 7.8 | nM | IC50 | J Med Chem (2022) 65: 285-302 [PMID:34942071] |
| ChEMBL | Inhibition of recombinant HDAC5 (unknown origin) | B | 8.11 | pIC50 | 7.8 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| histone deacetylase 6/Histone deacetylase 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1865] [GtoPdb: 2618] [UniProtKB: Q9UBN7] | ||||||||
| ChEMBL | Inhibition of human recombinant HDAC6 using fluorogenic HDAC substrate after 30 mins by fluorimetrc method | B | 7.27 | pKi | 54 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Inhibition of N-terminal GST-tagged recombinant human HDAC6 (1 to 1215 residues) expressed in Baculovirus infected insect cells using Boc-Lys(Ac)-AMC as substrate preincubated for 5 mins followed by substrate addition and further incubation for 90 mins measured after 15 mins by microplate reader based fluorescence assay | B | 7.52 | pKi | 30 | nM | Ki | Bioorg Med Chem (2019) 27: 115036-115036 [PMID:31431326] |
| ChEMBL | Inhibition of human HDAC6 | B | 8.82 | pKi | 1.5 | nM | Ki | Nat Chem Biol (2010) 6: 238-243 [PMID:20139990] |
| ChEMBL | Inhibition of human HDAC6 | B | 8.82 | pKi | 1.5 | nM | Ki | Bioorg Med Chem (2015) 23: 5151-5155 [PMID:25637120] |
| ChEMBL | Competitive inhibition of HDAC6 using KI-104 as substrate by fluorescence assay | B | 9.15 | pKi | 0.7 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of HDAC6 (unknown origin) after 60 mins by fluorescence assay | B | 6.52 | pIC50 | <300 | nM | IC50 | J Med Chem (2013) 56: 4816-4820 [PMID:23672185] |
| ChEMBL | Inhibition of human KDAC6 using FITC-labeled histone H4 acetylated peptide as substrate after 60 mins by fluorescence assay | B | 6.89 | pIC50 | 130 | nM | IC50 | Eur J Med Chem (2017) 127: 531-553 [PMID:28109947] |
| ChEMBL | Inhibition of HDAC6 (unknown origin) | B | 6.91 | pIC50 | 123.8 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| ChEMBL | Determination of IC50 values for inhibition of enzymatic assay of human HDAC6 with custom peptide substrate | B | 7.27 | pIC50 | 53.6 | nM | IC50 | HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
| ChEMBL | Inhibition of HADC6 (unknown origin) | B | 7.82 | pIC50 | <15 | nM | IC50 | J Med Chem (2020) 63: 23-39 [PMID:31415174] |
| ChEMBL | Inhibition of HDAC6 (unknown origin) | B | 7.82 | pIC50 | 15 | nM | IC50 | J Med Chem (2022) 65: 3080-3097 [PMID:35148101] |
| ChEMBL | Inhibition of HDAC6 (unknown origin) | B | 7.96 | pIC50 | 11 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| ChEMBL | Inhibition of HDAC6 (unknown origin) expressed in HEK293 cells using [3H]acetylated human histone H4 peptide as substrate by scintillation counting | B | 7.96 | pIC50 | 11 | nM | IC50 | Drug Metab Dispos (2012) 40: 1041-1050 [PMID:22344701] |
| ChEMBL | Inhibition of recombinant HDAC6 (unknown origin) | B | 7.98 | pIC50 | 10.5 | nM | IC50 | J Med Chem (2016) 59: 8967-9004 [PMID:27606546] |
| ChEMBL | Inhibition of recombinant HDAC6 (unknown origin) | B | 7.98 | pIC50 | 10.5 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant HDAC6 (unknown origin) using Boc-Lys(acetyl)-AMC as substrate preincubated for 1 hr followed by substrate addition and measured after 2 hrs by fluorescence based micro plate reader analysis | B | 7.98 | pIC50 | 10.5 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of recombinant HDAC6 (unknown origin) | B | 7.98 | pIC50 | 10.5 | nM | IC50 | J Med Chem (2021) 64: 3392-3426 [PMID:33661013] |
| ChEMBL | Inhibition of recombinant His6/GST-tagged human HDAC6 expressed in baculovirus infected High5 insect cells using Boc-Lys(epsion-acetyl)-AMC as substrate after 24 hrs by fluorescence based assay | B | 8.22 | pIC50 | 6.09 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of HDAC6 (unknown origin) using Ac-peptide-AMC as substrate incubated for 1 hr by fluorescence method | B | 8.25 | pIC50 | 5.6 | nM | IC50 | J Med Chem (2021) 64: 15379-15401 [PMID:34648295] |
| ChEMBL | Inhibition of full length human recombinant HDAC6 expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 8.38 | pIC50 | 4.16 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| ChEMBL | Inhibition of human recombinant HDAC6 using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 8.4 | pIC50 | 4 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition of HDAC6 (unknown origin) | B | 8.6 | pIC50 | 2.5 | nM | IC50 | Eur J Med Chem (2022) 229: 114053-114053 [PMID:34974338] |
| ChEMBL | Inhibition of human recombinant HDAC6 expressed in baculovirus coexpressed in fall armyworm Sf9 cells using carboxyfluorescein (FAM)-labeled acetylated/ trifluoroacetylated peptide as substrate after 60 mins by fluorescence assay | B | 8.7 | pIC50 | 2 | nM | IC50 | Bioorg Med Chem (2016) 24: 4008-4015 [PMID:27377864] |
| ChEMBL | Inhibition of HDAC6 in human A2780S cells assessed as tubulin acetylation incubated for 6 hrs by cytoblot assay | B | 6.82 | pEC50 | 150.71 | nM | EC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| GtoPdb | - | - | 7.21 | pEC50 | 61 | nM | EC50 | Biochem J (2008) 409: 581-9 [PMID:17868033] |
| histone deacetylase 7/Histone deacetylase 7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2716] [GtoPdb: 2661] [UniProtKB: Q8WUI4] | ||||||||
| ChEMBL | Inhibition of human HDAC7 | B | 5.34 | pKi | 4550 | nM | Ki | Nat Chem Biol (2010) 6: 238-243 [PMID:20139990] |
| ChEMBL | Inhibition of human HDAC7 | B | 5.34 | pKi | 4550 | nM | Ki | Bioorg Med Chem (2015) 23: 5151-5155 [PMID:25637120] |
| ChEMBL | Inhibition of human recombinant HDAC7 using fluorogenic HDAC substrate class 2a after 45 mins by fluorimetrc method | B | 6.2 | pKi | 630 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Competitive inhibition of HDAC7 using KI-104 as substrate by fluorescence assay | B | 8.64 | pKi | 2.3 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of human N-terminal GST-tagged HDAC7 (518 to end residues) expressed in baculovirus infected Sf9 cells using Ac-Leu-Gly-Lys(Tfa)-AMC as susbtrate after 24 hrs by fluorescence based assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of N-terminal GST-tagged human recombinant HDAC7 (518 to end residues) expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 5.36 | pIC50 | 4354 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| ChEMBL | Inhibition of recombinant HDAC7 (unknown origin) using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 5.36 | pIC50 | 4354 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition of N-terminal GST-tagged human recombinant HDAC7 (518 to end residues) expressed in baculovirus coexpressed in fall armyworm Sf9 cells using carboxyfluorescein (FAM)-labeled acetylated/ trifluoroacetylated peptide as substrate after 60 mins by fluorescence assay | B | 5.55 | pIC50 | 2830 | nM | IC50 | Bioorg Med Chem (2016) 24: 4008-4015 [PMID:27377864] |
| ChEMBL | Inhibition of HDAC7 (unknown origin) | B | 6.27 | pIC50 | 531 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| ChEMBL | Inhibition of recombinant HDAC7 (unknown origin) | B | 6.27 | pIC50 | 531 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of human recombinant HDAC7 using Boc-Lys(triflouroacetyI)-AMC substrate incubated for 2 hrs by fluorescence based assay | B | 6.27 | pIC50 | 531 | nM | IC50 | J Med Chem (2022) 65: 285-302 [PMID:34942071] |
| ChEMBL | Inhibition of HDAC7 (unknown origin) | B | 8.09 | pIC50 | 8.2 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| GtoPdb | - | - | 7.85 | pEC50 | 14 | nM | EC50 | Biochem J (2008) 409: 581-9 [PMID:17868033] |
| Histone deacetylase 8 in Schistosoma mansoni (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3797017] [UniProtKB: A5H660] | ||||||||
| ChEMBL | Inhibition of Schistosoma mansoni KDAC8 using (FAM)-labeled peptide as substrate after 60 mins by microfluidic assay | B | 6.35 | pIC50 | 450 | nM | IC50 | Bioorg Med Chem (2017) 25: 2105-2132 [PMID:28259528] |
| histone deacetylase 8/Histone deacetylase 8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3192] [GtoPdb: 2619] [UniProtKB: Q9BY41] | ||||||||
| ChEMBL | Inhibition of C-terminal His-fusion tagged/N-terminal Strep-2 tagged recombinant human HDAC8 (1 to 377 residues) expressed in insect cells using Boc-Lys(TFa)-AMC as substrate preincubated for 5 mins followed by substrate addition and further incubation for 90 mins measured after 15 mins by microplate reader based fluorescence assay | B | 6.12 | pKi | 750 | nM | Ki | Bioorg Med Chem (2019) 27: 115036-115036 [PMID:31431326] |
| ChEMBL | Inhibition of human recombinant HDAC8 using fluorogenic HDAC substrate after 15 mins by fluorimetrc method | B | 6.77 | pKi | 170 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Activity of human HDAC8 | B | 6.98 | pKi | 105 | nM | Ki | Nat Chem Biol (2010) 6: 238-243 [PMID:20139990] |
| ChEMBL | Inhibition of human HDAC8 | B | 6.98 | pKi | 105 | nM | Ki | Bioorg Med Chem (2015) 23: 5151-5155 [PMID:25637120] |
| ChEMBL | Competitive inhibition of HDAC8 using KI-104 as substrate by fluorescence assay | B | 7.66 | pKi | 22 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of HDAC8 (unknown origin) | B | 5.73 | pIC50 | 1864 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| ChEMBL | Inhibition of human KDAC8 after 60 mins by fluorescence assay | B | 5.75 | pIC50 | 1780 | nM | IC50 | Eur J Med Chem (2017) 127: 531-553 [PMID:28109947] |
| ChEMBL | Inhibition of HDAC8 (unknown origin) | B | 6.26 | pIC50 | 550 | nM | IC50 | J Med Chem (2022) 65: 3080-3097 [PMID:35148101] |
| ChEMBL | Inhibition of HADC8 (unknown origin) | B | 6.26 | pIC50 | 550 | nM | IC50 | J Med Chem (2020) 63: 23-39 [PMID:31415174] |
| ChEMBL | Inhibition of HDAC8 (unknown origin) after 60 mins by fluorescence assay | B | 6.52 | pIC50 | <300 | nM | IC50 | J Med Chem (2013) 56: 4816-4820 [PMID:23672185] |
| ChEMBL | Inhibition of his-strep-tagged HDAC8 (unknown origin) expressed in SF9 cells using [3H]acetylated human histone H4 peptide as substrate by scintillation counting | B | 6.55 | pIC50 | 280 | nM | IC50 | Drug Metab Dispos (2012) 40: 1041-1050 [PMID:22344701] |
| ChEMBL | Inhibition of human recombinant HDAC8 using Boc-Lys(triflouroacetyI)-AMC substrate incubated for 2 hrs by fluorescence based assay | B | 6.56 | pIC50 | 277 | nM | IC50 | J Med Chem (2022) 65: 285-302 [PMID:34942071] |
| ChEMBL | Inhibition of HDAC8 (unknown origin) | B | 6.56 | pIC50 | 277 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| ChEMBL | Inhibition of recombinant HDAC8 (unknown origin) | B | 6.56 | pIC50 | 277 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| ChEMBL | Inhibition of C-terminal His-tagged full length human recombinant HDAC8 expressed in baculovirus coexpressed in fall armyworm Sf9 cells using carboxyfluorescein (FAM)-labeled acetylated/ trifluoroacetylated peptide as substrate after 60 mins by fluorescence assay | B | 6.64 | pIC50 | 231 | nM | IC50 | Bioorg Med Chem (2016) 24: 4008-4015 [PMID:27377864] |
| ChEMBL | Inhibition of recombinant human His6/GST-tagged HDAC8 expressed in baculovirus infected High5 insect cells using Ac-Lys-Tyr-Lys(epsilon-acetyl)-AMC as susbtrate after 24 hrs by fluorescence based assay | B | 7.7 | pIC50 | 19.79 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of human recombinant HDAC8 using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 8.3 | pIC50 | 5 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition of full length C-terminal His-tagged human recombinant HDAC8 expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 8.31 | pIC50 | 4.86 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| GtoPdb | - | - | 6.61 | pEC50 | 248 | nM | EC50 | Biochem J (2008) 409: 581-9 [PMID:17868033] |
| histone deacetylase 9/Histone deacetylase 9 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4145] [GtoPdb: 2620] [UniProtKB: Q9UKV0] | ||||||||
| ChEMBL | Inhibition of human HDAC9 | B | 5.49 | pKi | 3200 | nM | Ki | Nat Chem Biol (2010) 6: 238-243 [PMID:20139990] |
| ChEMBL | Inhibition of human HDAC9 | B | 5.49 | pKi | 3200 | nM | Ki | Bioorg Med Chem (2015) 23: 5151-5155 [PMID:25637120] |
| ChEMBL | Inhibition of human recombinant HDAC9 using fluorogenic HDAC substrate class 2a after 30 mins by fluorimetrc method | B | 6.08 | pKi | 830 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Competitive inhibition of HDAC9 using KI-104 as substrate by fluorescence assay | B | 8.92 | pKi | 1.2 | nM | Ki | J Med Chem (2011) 54: 4694-4720 [PMID:21634430] |
| ChEMBL | Inhibition of recombinant human C-terminal His-tagged HDAC9 (604 to 1066 residues) expressed in baculovirus infected Sf9 cells using Ac-Leu-Gly-Lys(Tfa)-AMC as substrate after 24 hrs by fluorescence based assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| ChEMBL | Inhibition of C-terminal His-tagged human recombinant HDAC9 (604 to 1066 residues) expressed in baculovirus coexpressed in fall armyworm Sf9 cells using carboxyfluorescein (FAM)-labeled acetylated/ trifluoroacetylated peptide as substrate after 60 mins by fluorescence assay | B | 5.57 | pIC50 | 2680 | nM | IC50 | Bioorg Med Chem (2016) 24: 4008-4015 [PMID:27377864] |
| ChEMBL | Inhibition of HDAC9 (unknown origin) | B | 6.04 | pIC50 | 922.2 | nM | IC50 | J Med Chem (2019) 62: 3171-3183 [PMID:30418766] |
| ChEMBL | Inhibition of recombinant HDAC9 (unknown origin) using AMC labeled AC-peptide as substrate incubated for 1 hr by fluorescence analysis | B | 6.05 | pIC50 | 888 | nM | IC50 | J Med Chem (2016) 59: 1455-1470 [PMID:26443078] |
| ChEMBL | Inhibition of C-terminal His-tagged human recombinant HDAC9 (604 to 1066 residues) expressed in baculovirus infected insect Sf9 cells using Ac-peptide-AMC as substrate assessed as release of AMC preincubated for 15 mins followed by substrate addition measured after 1 hr by fluorescence assay | B | 6.05 | pIC50 | 887.8 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| ChEMBL | Inhibition of HDAC9 (unknown origin) | B | 8.22 | pIC50 | 6 | nM | IC50 | Eur J Med Chem (2021) 209: 112887-112887 [PMID:33035922] |
| ChEMBL | Inhibition of human recombinant HDAC9 using Boc-Lys(triflouroacetyI)-AMC substrate incubated for 2 hrs by fluorescence based assay | B | 8.24 | pIC50 | 5.7 | nM | IC50 | J Med Chem (2022) 65: 285-302 [PMID:34942071] |
| ChEMBL | Inhibition of recombinant HDAC9 (unknown origin) | B | 8.24 | pIC50 | 5.7 | nM | IC50 | J Med Chem (2020) 63: 5501-5525 [PMID:32321249] |
| GtoPdb | - | - | 8.52 | pEC50 | 3 | nM | EC50 | Biochem J (2008) 409: 581-9 [PMID:17868033] |
| Human immunodeficiency virus type 1 Tat protein in Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)(HIV-1) (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4011] [UniProtKB: P04608] | ||||||||
| ChEMBL | Activation of Tat-mediated HIV1 transcription in J-Lat 10.6 cells harboring LTR driven GFP reporter co-expressing CMV driven RFP reporter assessed as LTR-driven gene expression incubated for 48 hr by FACSCalibur flow cytometry | B | 6.89 | pEC50 | 130 | nM | EC50 | J Med Chem (2019) 62: 5148-5175 [PMID:30973727] |
| Leukotriene A4 hydrolase/Leukotriene A4 hydrolase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4618] [GtoPdb: 1395] [UniProtKB: P09960] | ||||||||
| ChEMBL | Inhibition of recombinant human LTA4H Epoxide Hydrolase expressed in Escherichia coli BL21 (DE3) pLysS preincubated for 10 mins followed by addition of LTA4 as substrate measured after 15 mins by reverse-phase HPLC analysis | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2017) 60: 1817-1828 [PMID:28218840] |
| sirtuin 1/NAD-dependent deacetylase sirtuin 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4506] [GtoPdb: 2707] [UniProtKB: Q96EB6] | ||||||||
| ChEMBL | Inhibition of human recombinant SIRT1 using fluorogenic HDAC substrate after 20 mins by fluorimetrc method | B | 5 | pKi | >10000 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Inhibition of recombinant human N-terminal GST-tagged SIRT1 expressed in Escherichia coli using Ac-Arg-His-Lys-Lys(Ac)-AMC as susbtrate after 1 hr by fluorescence based assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| sirtuin 2/NAD-dependent deacetylase sirtuin 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4462] [GtoPdb: 2708] [UniProtKB: Q8IXJ6] | ||||||||
| ChEMBL | Inhibition of human recombinant SIRT2 using fluoro-lysine sirtuin 2 deacetylase substrate after 60 mins by fluorimetrc method | B | 5 | pKi | >10000 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Inhibition of recombinant human N-terminal GST-tagged SIRT2 expressed in Escherichia coli using Ac-Arg-His-Lys-Lys(Ac)-AMC as susbtrate after 2 hrs by fluorescence based assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| sirtuin 3/NAD-dependent deacetylase sirtuin 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4461] [GtoPdb: 2709] [UniProtKB: Q9NTG7] | ||||||||
| ChEMBL | Inhibition of human recombinant SIRT3 using fluoro-lysine sirtuin 2 deacetylase substrate after 45 mins by fluorimetrc method | B | 5 | pKi | >10000 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| ChEMBL | Inhibition of recombinant human N-terminal His-tagged SIRT3 expressed in Escherichia coli using Ac-Arg-His-Lys-Lys(Ac)-AMC as susbtrate after 2 hrs by fluorescence based assay | B | 4.7 | pIC50 | >20000 | nM | IC50 | J Med Chem (2020) 63: 804-815 [PMID:31855601] |
| sirtuin 7/NAD-dependent protein deacetylase sirtuin-7 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2163184] [GtoPdb: 2713] [UniProtKB: Q9NRC8] | ||||||||
| ChEMBL | Inhibition of SIRT7 (unknown origin) | B | 5 | pKi | >10000 | nM | Ki | Bioorg Med Chem Lett (2018) 28: 2985-2992 [PMID:30122227] |
| phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta/PI3-kinase p110-beta subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3145] [GtoPdb: 2154] [UniProtKB: P42338] | ||||||||
| ChEMBL | Inhibition of recombinant human p110beta expressed in baculovirus infected insect Sf9 cells incubated for 1 hr by ADP-gloreagen assay | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta/phosphoinositide-3-kinase regulatory subunit 1/PI3-kinase p110-delta/p85-alpha in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL2111432] [GtoPdb: 2155, 2503] [UniProtKB: O00329, P27986] | ||||||||
| ChEMBL | Inhibition of N-terminal His6-tagged recombinant full-length human p110delta/untagged recombinant full length human p85alpha expressed in baculovirus infected insect Sf9 cells incubated for 2 hrs by kinase-glo assay | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma/PI3-kinase p110-gamma subunit in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3267] [GtoPdb: 2156] [UniProtKB: P48736] | ||||||||
| ChEMBL | Inhibition of His-tagged full length recombinant human p110gamma expressed in baculovirus expression system incubated for 1 hr by ADP-gloreagen assay | B | 5 | pIC50 | >10000 | nM | IC50 | J Med Chem (2016) 59: 5488-5504 [PMID:27186676] |
| Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
| ChEMBL | Antimalarial activity against Plasmodium falciparum 3D7 by [3H]hypoxanthine uptake | F | 7.68 | pIC50 | 21 | nM | IC50 | J Med Chem (2009) 52: 2185-2187 [PMID:19317450] |
| ChEMBL | Antimalarial activity against Plasmodium falciparum infected in human erythrocytes preincubated for 48 hrs followed by [3H]-hypoxanthine addition measured after 24 hrs by scintillation counting assay | F | 8 | pIC50 | 10 | nM | IC50 | J Med Chem (2017) 60: 4780-4804 [PMID:28241112] |
| ChEMBL | Antimalarial activity against Plasmodium falciparum 3D7 infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation preincubated for 48 hrs followed by [3H]-hypoxanthine addition measured after 24 hrs by scintillation counting method | F | 8 | pIC50 | 10 | nM | IC50 | Eur J Med Chem (2018) 158: 801-813 [PMID:30245402] |
| ChEMBL | Antimalarial activity against Plasmodium falciparum Dd2 infected in human erythrocytes assessed as reduction in [3H]-hypoxanthine incorporation preincubated for 48 hrs followed by [3H]-hypoxanthine addition measured after 24 hrs by scintillation counting method | F | 8 | pIC50 | 10 | nM | IC50 | Eur J Med Chem (2018) 158: 801-813 [PMID:30245402] |
| Plasmodium falciparum histone deacetylase 1 in Plasmodium knowlesi [GtoPdb: 3072] | ||||||||
| GtoPdb | Parasite growth inhibition assay | - | 8.05 | pIC50 | 9 | nM | IC50 | Int J Parasitol Drugs Drug Resist (2017) 7: 42-50 [PMID:28107750] |
| Plasmodium falciparum histone deacetylase 1 in Plasmodium falciparum 3D7 [GtoPdb: 3072] [UniProtKB: Q7K6A1] | ||||||||
| GtoPdb | Parasite gametocyte viability assay | - | 6.03 | pIC50 | 935 | nM | IC50 | Sci Rep (2014) 4: 3743 [PMID:24434750] |
| GtoPdb | Parasite growth inhibition assay | - | 8 | pIC50 | 10 | nM | IC50 | Int J Parasitol Drugs Drug Resist (2015) 5: 117-26 [PMID:26199860] |
| Plasmodium falciparum histone deacetylase 1 in Plasmodium falciparum Dd2 [GtoPdb: 3072] | ||||||||
| GtoPdb | Parasite gametocyte viability assay | - | 6.83 | pIC50 | 148 | nM | IC50 | Sci Rep (2014) 4: 3743 [PMID:24434750] |
| GtoPdb | Parasite growth inhibition assay | - | 7.52 | pIC50 | 30 | nM | IC50 | Int J Parasitol Drugs Drug Resist (2015) 5: 117-26 [PMID:26199860] |
| Plasmodium falciparum histone deacetylase 1 in Plasmodium falciparum HB3 [GtoPdb: 3072] | ||||||||
| GtoPdb | Parasite gametocyte viability assay | - | 6.93 | pIC50 | 118 | nM | IC50 | Sci Rep (2014) 4: 3743 [PMID:24434750] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
